Selective PCR for the detection of HIV-1 drug resistance mutations in the follow-up of HIV-1 infected patients

Kristel Van Laethem; Kristien Van Vaerenbergh; JC Schmit; De Vroey; Rob Schuurman; S Sprecher; P Hermans; De Clercq Erik; Jan Desmyter; Anne‐Mieke Vandamme

Related publications

Article1998

Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations

Ilse Vanderlinden, Theresa Puig, R. Rossau, Jan Desmyter, De Clercq Erik, Bonaventura Clotet, Anne‐Mieke Vandamme, Jean‐Claude Schmit, Lı́dia Ruiz, Lieven Stuyver, Kristel Van Laethem

Article2001

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

Kristien Van Vaerenbergh, Laurent Debaisieux, Nancy De Cabooter, Cathérine Declercq, K. Desmet, Katrien Fransen, Bart Maes, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, Lieven Stuyver, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article1996

Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)

Jean‐Claude Schmit, Lı́dia Ruiz, Bonaventura Clotet, Antoni Raventós, Jordi Tor, John M. Leonard, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme

Article2000

Initiation of HAART in drug naive HIV-1 patients prevents viral breakthrough for up to 43 months in 60% of the patients

Anne‐Mieke Vandamme, Kristien Van Vaerenbergh, JC Schmit, B. Schmidt, H Walter, Elodie Fontaine, Marie‐Paule Schmitt, Kristel Van Laethem, Astrid Rascu, De Vroey, Mathias Grünke, Phillip A. Low, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Thomas Harrer

Article2007

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy

Antonio Carvajal‐Rodríguez, Keith A. Crandall, David Posada